Please login to the form below

Not currently logged in
Email:
Password:

Genzyme makes Brendan Martin UK and Ireland manager

Replaces Paul Drohan who returns to Canada

Genzyme Brendan MartinBrendan Martin has been appointed general manager for the UK and Ireland at Genzyme.

Martin, who was previously deputy general manager for UK and Ireland, replaces Paul Drohan who is returning home to Canada.

The appointment will see Martin take on responsibility for all the company's commercial activities in the region. These will mainly involve rare inherited diseases and immune conditions.

It is Martin's most senior role at Genzyme, where he has spent ten years, joining its lysosomal storage disorders business in Ireland in 2002, before being promted to business unit director in 2007.

Robin Kenselaar, head of Genzyme EMEA, said: “Brendan's appointment as general manager, UK and Ireland comes at a key time for the business as it builds its multiple sclerosis franchise and continues to develop in rare diseases.

“In his Genzyme career to date, Brendan has shown he is a leader with the experience, energy, vision and commitment to patients needed to move us forward.”

3rd December 2012

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Future Market Insights

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics